TrialHuman vaccines & immunotherapeutics2013

Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial.

Mahboobeh Safaeian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.